Orbimed Advisors LLC Insider Trades & Stock Holdings

Director · ADARx Pharmaceuticals, Inc. · Latest filing Sep 28, 2026

Orbimed Advisors LLC, Director at ADARx Pharmaceuticals, Inc. has 3 Form 4 trades on file since Jun 22, 2026 across 3 companies. Open-market activity: 2 purchases ($36.15M) and 1 sale ($39.01M), net -$2.86M. Latest filing: acquired 950K shares of $ADRX on Sep 28, 2026 at $17.

Trades on file

3

Open-market bought

$36.15M

Open-market sold

$39.01M

Net open-market

-$2.86M

Latest filing

Sep 28, 2026

All insider trades by Orbimed Advisors LLC

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 28, 2026	$ADRX	Buy (Open-market buy)	950K	$17	$16.15M						Director		—
Sep 21, 2026	$ETRA	Buy (Open-market buy)	1.33M	$15	$20M						Director		—
Jun 22, 2026	$ELVN	Sell (Open-market sale)	860.12K	$45.36	$39.01M			+10.6%	+15.0%				—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Orbimed Advisors LLC traded

• $ADRX
• $ETRA
• $ELVN

Frequently asked questions

Has Orbimed Advisors LLC been buying or selling stock?

Orbimed Advisors LLC has 2 open-market purchases and 1 open-market sale on file, net -$2.86M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Orbimed Advisors LLC's latest insider trade?

acquired 950K shares of $ADRX on Sep 28, 2026 at $17.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.